Upregulation of sterol C14-demethylase expression in Trypanosoma cruzi treated with sterol biosynthesis inhibitors.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLBIOPARA.2005.08.002PMID 16165233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Negative Regulatory Element Controls mRNA Abundance of the Leishmania mexicana Paraflagellar Rod Gene PFR2

  2003cited by this paper
• RNA-binding proteins and mRNA turnover in trypanosomes.

  2003cited by this paper
• Microarray profiling of gene expression during trypomastigote to amastigote transition in Trypanosoma cruzi.

  2003cited by this paper
• Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.

  2003cited by this paper
• Life without transcriptional control? From fly to man and back again

  2002cited by this paper
• Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  2002cited by this paper
• Trypanosomatid transcription factors: Waiting for Godot

  2002cited by this paper
• A Common Mechanism of Stage-regulated Gene Expression inLeishmania Mediated by a Conserved 3′-Untranslated Region Element*

  2002cited by this paper
• Potent Anti-Trypanosoma cruzi Activities of Oxidosqualene Cyclase Inhibitors

  2001cited by this paper
• Functionally Different AU- and G-rich cis-Elements Confer Developmentally Regulated mRNA Stability inTrypanosoma cruzi by Interaction with Specific RNA-binding Proteins*

  2001cited by this paper
• Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Developmental regulation of heat shock protein 83 in Leishmania. 3' processing and mRNA stability control transcript abundance, and translation id directed by a determinant in the 3'-untranslated region.

  2001cited by this paper
• Poly(A)-binding protein I of Leishmania: functional analysis and localisation in trypanosomatid parasites.

  2000cited by this paper
• Identification of a putative regulatory element in the 3'-untranslated region that controls expression of HSP70 in Leishmania infantum.

  2000cited by this paper
• Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan ParasiteTrypanosoma (Schizotrypanum) cruzi in Immunocompetent and Immunosuppressed Murine Hosts

  2000cited by this paper
• Amastin mRNA Abundance in Trypanosoma cruzi Is Controlled by a 3′-Untranslated Region Position-dependent cis-Element and an Untranslated Region-binding Protein

  2000cited by this paper
• Structure of a regulatory 3' untranslated region from Trypanosoma brucei.

  1999cited by this paper
• Expression of Trypanosoma cruzi surface antigen FL-160 is controlled by elements in the 3' untranslated, the 3' intergenic, and the coding regions.

  1999cited by this paper
• Antiproliferative Effects and Mechanism of Action of SCH 56592 against Trypanosoma (Schizotrypanum)cruzi: In Vitro and In Vivo Studies

  1998cited by this paper
• Differential Regulation of Multiple Glucose Transporter Genes in Leishmania mexicana *

  1998cited by this paper
• The current status of antiparasite chemotherapy

  1997cited by this paper
• Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease.

  1997cited by this paper
• Mechanisms of developmental regulation in Trypanosoma brucei: a polypyrimidine tract in the 3'-untranslated region of a surface protein mRNA affects RNA abundance and translation.

  1997cited by this paper
• Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents.

  1996cited by this paper
• Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870

  1996cited by this paper
• Antifungal agents: chemotherapeutic targets and immunologic strategies

  1996cited by this paper
• Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.

  1995cited by this paper
• Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing.

  1995cited by this paper
• Analyzing expression of the calmodulin and ubiquitin-fusion genes of Trypanosoma cruzi using simultaneous, independent dual gene replacements.

  1994cited by this paper
• A common pyrimidine-rich motif governs trans-splicing and polyadenylation of tubulin polycistronic pre-mRNA in trypanosomes.

  1994cited by this paper
• Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up.

  1994cited by this paper
• Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease

  1993cited by this paper
• Regulation of partitioned sterol biosynthesis in Saccharomyces cerevisiae

  1992cited by this paper
• Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi

  1990cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Sterols of parasitic protozoa and helminths.

  1989cited by this paper
• Fl-160. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue

  1989cited by this paper
• Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi

  1988cited by this paper
• Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi.

  1987cited by this paper
• In vitro and in vivo effects of itraconazole against Trypanosoma cruzi.

  1986cited by this paper

• Green Pesticide Research and Development Integrating Molecular Targets, Mechanisms, Resistance, and Innovation in Theory and Technology.

  2025cites this paper
• Chemical Inhibition of Sterol Biosynthesis

  2024cites this paper
• Druggable Sterol Metabolizing Enzymes in Infectious Diseases: Cell Targets to Therapeutic Leads

  2024cites this paper
• Simvastatin Resistance of Leishmania amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors

  2022cites this paper
• Major kinds of drug targets in Chagas disease or American Trypanosomiasis.

  2019cites this paper
• In silico identification of novel antagonists and binding insights by structural and functional analyses of guanylate kinase of Leishmania donovani and interaction with inhibitors

  2017cites this paper
• Research & development and distribution of medicines for eliminating tropical diseases: Introduction of our activities as an example of the approach by pharmaceutical industries.

  2017cites this paper
• [Development and Distribution of Drugs for NTDs: Efforts of One Pharmaceutical Company].

  2016cites this paper
• Evaluation of Pseudomonas and Trichoderma enriched organic amendment against Alternaria leaf spot of Withania somnifera

  2015cites this paper
• New treatments for Chagas disease and the relationship between chagasic patients and cancers

  2014cites this paper
• In Vitro Imaging of Trypanosoma cruzi Host Infection Systems for Evaluation of Compound Activity

  2014cites this paper
• Avaliação da atividade anti-Trypanosoma cruzi do derivado triazólico Ravuconazol utilizando o cão como modelo experimental.

  2013cites this paper
• Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target

  2013cites this paper
• Contribution to New Therapies for Chagas Disease

  2013cites this paper
• Citocromo P450 reductasas y metabolismo redox en Trypanosoma cruzi

  2013cites this paper
• The stepwise selection for ketoconazole resistance induces upregulation of C14-demethylase (CYP51) in Leishmania amazonensis.

  2012cites this paper
• Tomatidine promotes the inhibition of 24-alkylated sterol biosynthesis and mitochondrial dysfunction in Leishmania amazonensis promastigotes

  2012cites this paper
• Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.

  2012cites this paper
• Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.

  2011cites this paper
• Drug discovery for neglected tropical diseases at the Sandler Center.

  2011cites this paper
• A decade of targets and patented drugs for chemotherapy of Chagas disease.

  2011cites this paper
• Drug discovery for neglected tropical diseases

  2011cites this paper
• The NADPH-cytochrome P450 reductase family in Trypanosoma cruzi is involved in the sterol biosynthesis pathway.

  2011cites this paper
• Transcriptomic analyses of the avirulent protozoan parasite Trypanosoma rangeli.

  2010cites this paper
• dentification of inhibitors for putative malaria drug targets among novel ntimalarial compounds regory

  2010cites this paper
• Avaliação da utilização do colesterol exógeno por Leishmania amazonensis como possível alvo farmacológico

  2009cites this paper
• Multiple NADPH-cytochrome P450 reductases from Trypanosoma cruzi suggested role on drug resistance.

  2008cites this paper
• Characterization of electronic structure and physicochemical properties of antiparasitic nifurtimox analogues: A theoretical study

  2008cites this paper
• Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

  2007cites this paper
• Sterol 14α-Demethylase Cytochrome P450 (CYP51), a P450 in all Biological Kingdoms

  2007cites this paper
• Effect of Antimicrobial Compounds on Balamuthia mandrillaris Encystment and Human Brain Microvascular Endothelial Cell Cytopathogenicity

  2007cites this paper
• An insight on targets and patented drugs for chemotherapy of Chagas disease.

  2007cites this paper
• Drug discovery and development for neglected parasitic diseases

  2006cites this paper
• Author's Personal Copy Transcriptomic Analyses of the Avirulent Protozoan Parasite Trypanosoma Rangeli

  year unknowncites this paper